On-body injector delivery of subcutaneous teprotumumab achieves clinically meaningful proptosis reduction in phase 3 thyroid eye disease study.

NTR-1011 demonstrated a favorable safety, tolerability, and immunogenicity profile across multiple dose levels of intravenous (IV) and ...

As cardiovascular function ages, the heart becomes fibrotic, leading to reduced contraction, impaired vascular function, and ...

While an abdominal bulge might appear to be a setback for body look, it actually indicates the presence of fat deep within ...

Research on yo-yo dieting has long indicated it can be harmful for your health. But a recent paper has now suggested yo-yo ...

A 51-year-old man with advanced pancreatic cancer presented to General Hospital of Southern Theater Command (Guangzhou, China) in December, 2025, with a 3-week history of rapidly spreading, painful ...

Abstract: The subcutaneous mechanical response of the fingertip is highly anisotropic due to the presence of a network of collagen fibers linking the outer skin layer to the bone. The impact of this ...

With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed at ensuring its own PD-1 stalwart doesn’t miss out on the action. GSK, ...

Please provide your email address to receive an email when new articles are posted on . Incorrect injection of an influenza vaccine can cause nodule formation or lipomas. Risk was lower when ...

Treatment with GRI-0621, an experimental oral therapy from GRI Bio, boosts lung function in adults with idiopathic pulmonary fibrosis (IPF), according to top-line data from a Phase 2a clinical trial.

Susan Bard, MD, is a board-certified general and procedural dermatologist with the American Board of Dermatology and a Fellow of the American College of Mohs Surgery. You can try regular scalp ...

From silver nanofibers to smart, sensory-packed dressings, the next generation of wound-healing technology is blurring the line between biology and engineering. A new review has looked at what’s ...